Kore Private Wealth’s AbbVie ABBV Stock Holding History

Kore Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$558K	Buy	4,154 +375	+10%	+$53.8K	0.1%	122
2022 Q2	$579K	Sell	3,779 -414	-10%	-$63.3K	0.09%	144
2022 Q1	$680K	Buy	4,193 +688	+20%	+$99.9K	0.09%	146
2021 Q4	$475K	Sell	3,505 -4,111	-54%	-$486K	0.06%	177
2021 Q3	$821K	Sell	7,616 -203	-3%	-$23.2K	0.09%	176
2021 Q2	$881K	Buy	7,819 +3,546	+83%	+$399K	0.1%	148
2021 Q1	$462K	Sell	4,273 -410	-9%	-$43.9K	0.06%	200
2020 Q4	$502K	Sell	4,683 -117	-2%	-$11.2K	0.08%	165
2020 Q3	$420K	Buy	4,800 +153	+3%	+$14.4K	0.08%	150
2020 Q2	$456K	Sell	4,647 -267	-5%	-$23.5K	0.09%	135
2020 Q1	$374K	Buy	4,914 +1,718	+54%	+$146K	0.09%	141
2019 Q4	$283K	Buy	3,196 +432	+16%	+$35.9K	0.05%	204
2019 Q3	$202K	Buy	+2,764	New	+$189K	0.05%	214
2019 Q2	–	Sell	-2,761	Closed	-$223K	–	232
2019 Q1	$223K	Sell	2,761 -141	-5%	-$11.5K	0.05%	190
2018 Q4	$268K	Buy	+2,902	New	+$255K	0.07%	166

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kore Private Wealth's ABBV Position: Q3 2022 in Review

Kore Private Wealth increased its AbbVie (ABBV) stake by 9.9% in Q3 2022, buying an estimated $53.8K and bringing the position to 4,154 shares worth $558K. The position accounts for 0.1% of the portfolio, ranked #122.

Kore Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 15 quarters since. The position peaked at $881K in Q2 2021. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Kore Private Wealth held 4,154 shares of AbbVie worth $558K as of Q3 2022.
Kore Private Wealth bought 375 AbbVie shares in Q3 2022, an estimated $53.8K.
AbbVie made up 0.1% of Kore Private Wealth's portfolio in Q3 2022, its #122 holding.
Kore Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 15 quarters since.
Kore Private Wealth's AbbVie position peaked at $881K in Q2 2021.
2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.